1. Background {#sec222592}
=============

Bone mass decreases with aging and results in osteoporosis in elderly subjects. Low bone mass is an important public health problem in both aged females and males because of its consequent bone fractures and resultant morbidities, disability as well as social costs ([@A39662R1]). Similar to postmenopausal females, osteoporosis is also prevalent in males and almost 25% of males older than 50 years old, will experience an osteoporotic fracture ([@A39662R2]).

Bone mineral density (BMD) loss is an important contributor of fracture particularly in subjects aged 65 years and over ([@A39662R3]). Mortality of hip fracture in males is two to three folds greater than in females ([@A39662R4]). Only 21% of males with hip fractures can live independently in the community during the following year; other patients require home care or institutionalization ([@A39662R5]). In elderly males, decreased bone mass and increased risk of fracture have been attributed to low levels of sex steroids by aging, as well as age-related osteoblast dysfunction ([@A39662R6]).

The results of a longitudinal study, over a 4.6-year follow-up period indicated that combination of low estradiol and low testosterone was associated with significantly faster BMD loss in males ([@A39662R7]). The results of a systematic review of 55 studies showed that factors such as age, low body mass index (BMI), current smoking, excessive alcohol use, chronic corticosteroid use, hypogonadism, diabetes, prior fractures, history of falls and stroke, are risk factors of low bone mass in males ([@A39662R4]).

Secondary causes of osteoporosis are also common, and in a study of elderly males and females the causes of osteoporosis were treatable in a significant proportion of patients ([@A39662R8]). Several previously published studies have addressed the causes of bone loss in elderly subjects ([@A39662R8]-[@A39662R15]). Nonetheless, the results of studies regarding the relationship between BMD changes and many associated factors especially obesity, metabolic syndrome and diabetes, varied across various studies ([@A39662R11], [@A39662R12], [@A39662R14]-[@A39662R16]). This issue may be attributed to characteristics of the study subjects, such as ethnicity, lifestyle, demographic features or study design. In addition, age, level of daily physical activities, education and serum vitamin D may differently affect the results across different study populations.

Contribution of the associated factors in the development of low BMD differs among various studies. In one study of community-dwelling white males, aged \> 65 years old, bioavailable testosterone accounted for 20.7%, physical activity score for 9% and BMI for 6.5% of BMD variance ([@A39662R10]). Awareness of the associated factors of bone changes in elderly patients is of particular importance because a number of risk factors can be treated or modified ([@A39662R8], [@A39662R9]).

Prevalence of osteoporosis in Iranian populations has been investigated in several studies but the results are conflicting ([@A39662R17]). A number of anthropometric, nutritional and economical factors have been investigated and have concluded that in the Iranian population, BMD is lower than European and US populations due to differences in lifestyle, ethnicity, nutrition and anthropometrics ([@A39662R18]).

We have shown the associated factors of osteoporosis in elderly females living in northern Iran ([@A39662R19]) yet epidemiological data regarding the prevalence and the associated factors of BMD in elderly males are lacking. This issue justifies a study to address the associated factors of low BMD in older males. In particular, many clinical conditions such as diabetes, obesity, metabolic syndrome, and vitamin D deficiency, which diversely influence BMD, are highly prevalent in this area ([@A39662R20]-[@A39662R24]).

2. Objectives {#sec222593}
=============

The aim of this study was to determine the association between BMD as well as osteoporosis and several clinical, biochemical, and socio-demographic characteristics in elderly males aged 60 years and older. The study population consisted of all male participants of the Amirkola health and ageing project (AHAP) cohort ([@A39662R23]).

Since the participants of this cohort had similar characteristics regarding ethnicity, nutrition, lifestyle, body habitus and socio-demographic features, the results of this study are expected to have a low level of bias.

3. Methods {#sec222595}
==========

The patients of this study were selected according to the inclusion criteria for male participants of the cohort of the Amirkola health and ageing project (AHAP). This project was conducted in Amirkola, Babol, a town located in the southern shore of the Caspian Sea, north of Iran. The project was funded by the vice-chancellery of Research and Technology, Babol University of Medical Sciences for investigation of geriatric medical problems such as falling, bone fragility and fractures, cognitive impairment and dementia, poor mobility and functional dependence. The baseline of this project was done during years 2011 and 2012. All inhabitants aged 60 years and over were invited to participate in this study and 72.3% of the invited subjects participated and completed the project ([@A39662R23]). All male participants, who performed bone densitometry, entered the study. Individuals with acute or chronic inflammatory musculoskeletal diseases, systemic gastrointestinal, renal, respiratory diseases and patients, who were receiving anti-osteoporosis treatment and oral corticosteroids, were excluded. Informed consent was obtained from all patients and the proposal of this study was approved by the ethic committee of the Babol University of Medical Sciences, Babol, Iran.

Data were collected for age, marital status, smoking, prior history of fractures, taking medication such as calcium and vitamin D supplementation as well and inhaled corticosteroids, anti-osteoporosis treatment, occupation, educational level, physical activity, quadriceps muscle strength (QMS), BMI, hemoglobin, serum creatinine, calcium, phosphate, serum 25-hydroxyvitamin D concentration, ferritin, thyroid function test, testosterone and parathyroid hormone level ([Table 1](#tbl55891){ref-type="table"}). The QMS was measured in both limbs by hand -helded dynamometry . In this method, isotonic knee joint extension was performed in a seated position against a fixed dynamometer which was positioned 5 cm above the lateral malleolus of the tibia. The average value of three measurements was considered for analysis. Details of the data collection and the specific methods for blood analysis have been described elsewhere ([@A39662R23]). Osteoporotic fractures were confirmed based on self-reported data and medical records. Traumatic bone fractures were excluded. Diabetes was confirmed by history and fasting blood sugar measurement and metabolic syndrome was confirmed by ATP III criteria and abdominal obesity was confirmed by waist circumference \> 95 cm ([@A39662R22]). The BMD was measured in the lumbar spine (LS) at L2 - L4 regions and femoral neck (FN) by dual energy X-ray absorptiometry (DXA) method using the Lexxos densitometer. The precision errors of BMD measurements were 1.3 % for total hip, 2% for femoral neck and 2.3% for spine. The results of BMD measurement were expressed as BMD g/cm^2^, BMD T-score, BMD Z -score. Osteoporosis was diagnosed according to the International Society for Clinical Densitometry criteria defined as BMD values of 2.5 SD or more below the mean value for young adults (T-score ≤ - 2.5) at either FN or LS measurement sites (one diagnostic category) ([@A39662R25]). The reference value for determination of T- score was provided by the manufacturer (Lexxos).

###### Comparison of Clinical and Biochemical Characteristics in Elderly Males With and Without Osteoporosis Recruited From the Amirkola Cohort Study^[a](#fn58672){ref-type="table-fn"},[b](#fn58673){ref-type="table-fn"}^

  Patients Characteristics                                                     Osteoporosis Present^[c](#fn58674){ref-type="table-fn"}^   Osteoporosis Absent   P Values
  ---------------------------------------------------------------------------- ---------------------------------------------------------- --------------------- ----------
  **No. of patients**                                                          90                                                         463                   
  **Age[^d^](#fn58675){ref-type="table-fn"}, y**                               71.4 ± 8.1                                                 68.5 ± 7              0.001
  **Body mass index[^d^](#fn58675){ref-type="table-fn"}, kg/ m** ^**2**^       23.5 ± 3.5                                                 26.6 ± 3.9            0.001
  \< 25                                                                        67 (74.4)                                                  154 (33.2)            
  25 - 29                                                                      18 (20)                                                    224 (48.4)            0.001
  \> 30                                                                        5 (5.6)                                                    85 (18.4)             0.001
  **Total physical activity score** ^**[d](#fn58675){ref-type="table-fn"}**^   97 ± 67                                                    110 ± 69.8            0.092
  **Quadriceps muscle strength[^d^](#fn58675){ref-type="table-fn"},kg**        23.4 ± 8.3                                                 30.1 ±3.9             0.001
  **Education level, No. (%)**                                                                                                                                  0.023
  Illiterate                                                                   62 (68.8)                                                  258 (55.7)            
  Primary school                                                               23 (25.6)                                                  136 (29.4)            0.023
  High school and university                                                   5 (5.6)                                                    69 (14.9)             0.004
  **Inhaled /oral corticosteroid users**                                       11 (12.2)                                                  23 (5)                0.009
  **Smokers**                                                                  30 (33.3)                                                  157 (33.9)            0.916
  **History of fractures, No (%)**                                             37 (41.1)                                                  121 (26.1)            0.004
  **Vitamin D[^d^](#fn58675){ref-type="table-fn"}, ng/mL**                     36.9 ± 27.8                                                30.7 ± 25.4           0.051
  \< 20                                                                        28 (31)                                                    164 (35.4)            0.088
  20 - 20                                                                      27 (30)                                                    172 (37.2)            
  \> 30                                                                        35 (38.9)                                                  127 (27.4)            
  **Hemoglobin[^d^](#fn58675){ref-type="table-fn"}, gr/dL**                    13.7 ±1.4                                                  14.5 ± 1.4            0.001
  **Serum creatinine[^d^](#fn58675){ref-type="table-fn"}, mg/dL**              1.002 ±0.22                                                1.03 ± 0.22           0.266
  **Serum Iron[^d^](#fn58675){ref-type="table-fn"}, µg/dL**                    80.8 ± 33.7                                                91.4 37.4             0.009
  **TIBC[^d^](#fn58675){ref-type="table-fn"}, µg/dL**                          282 ± 46.6                                                 278 ±42               0.404
  **Serum ferritin[^d^](#fn58675){ref-type="table-fn"}, ng/mL**                143.4 ± 106                                                171.3 ± 116           0.036
  **Serum calcium[^d^](#fn58675){ref-type="table-fn"}, mg/dL**                 9.2 ± 0.42                                                 463 ± 9.2             0.611
  **Serum phosphate[^d^](#fn58675){ref-type="table-fn"}, mg/dL**               3.9 ± 0.63                                                 3.8 ±0.59             0.063
  **Parathyroid hormone[^d^](#fn58675){ref-type="table-fn"}, pg/mL**           53.9 ± 38                                                  53.9 ±40              0.99
  **Serum Testosterone[^d^](#fn58675){ref-type="table-fn"}, ng/dL**            4.3 ± 3.5                                                  4.8 ± 4.4             
  **Diabetes, No. (%)**                                                        11 (12.2)                                                  131 (28.3)            0.001
  **Metabolic syndrome, No. (%)**                                              42 (46.7)                                                  325 (70.2)            0.001
  **Serum TSH, µ IU/mL, No. (%)**                                                                                                                               0.45
  \< 0.5                                                                       0                                                          8 (1.7)               
  0.5 - 5                                                                      79 (87.8)                                                  400 (86.4)            
  \> 5                                                                         11 (12.2)                                                  55 (11.9)             
  **Abdominal obesity, No. (%)** ^**[e](#fn58676){ref-type="table-fn"}**^      9 (10)                                                     141 (30.5)            0.001
  **Anemia, No. (%)** ^**[f](#fn58677){ref-type="table-fn"}**^                 24 (29.6)                                                  66 (14)               0.001

^a^Chi square test with calculation of 95% CI.

^b^Multiple regression analysis with calculation of 95% CI.

^c^Osteoporosis at either femoral neck or lumbar spine according to International society for clinical densitometry (ISCD) criteria.

^d^mean ± SD.

^e^WC, Waist Circumference \> 95 cm.

^f^Anemia defined as hemoglobin \< 13 gr/dL.

3.1. Statistical Analysis {#sec222594}
-------------------------

In the statistical analyses, the proportion of osteoporosis at either FN or LS was determined and patients with and without osteoporosis were compared according to BMD parameters, frequency of clinical conditions, demographic and biochemical characteristics ([Table 1](#tbl55891){ref-type="table"}). The correlation was determined using the Pearson test. Association was determined by chi square test by calculation of odds ratio (OR) with 95% Confidence Interval (95%CI). Multivariate regression analysis with simultaneous adjustment for all covariates (was used to estimate the independent association between osteoporosis and demographic, clinical and biochemical factors by calculation of adjusted OR (95% CI). The SPSS software version 18 was used for the analysis.

4. Results {#sec222596}
==========

A total of 553 males with mean age of 70.0 ± 7.7 years were studied. Two hundred and twenty nine subjects (41.4%) were \> 70 years old. Ninety out of 553 subjects (16.2%) had osteoporosis at either LS or FN. Mean age of osteoporotic patients was significantly higher than those without osteoporosis (71.4 ± 8.1 vs. 68.5 ± 7 years, P = 0.001).

The BMD gr/cm^2^ at both measurement sites in patients with and without osteoporosis is shown in [Table 2](#tbl55892){ref-type="table"}. As expected, all BMD parameters at both FN and LS were significantly lower in osteoporotic patients as compared with patients without osteoporosis. The magnitudes of FMBMD and LSBMD in osteoporotic patients were lower by 24.7% and 26.8%, respectively ([Table 2](#tbl55892){ref-type="table"}). History of fractures was found in 158 subjects with mean age of 68.2 ± 7.16 years. Subjects with fractures had significantly lower FNBMD and LSBMD but higher prevalence of osteoporosis ([Figure 1](#fig40682){ref-type="fig"}).

###### Comparison of Femoral Neck (FN) and Lumbar Spine (LS) Bone Mineral Density (BMD) in Elderly Males Aged 60 Years and Older as Participants of the Amirkola Cohort Study^[a](#fn58678){ref-type="table-fn"}^

  BMD Parameters             Osteoporosis^[b](#fn58679){ref-type="table-fn"}^ Positive, n = 90   Osteoporosis Negative, n = 463   P Values
  -------------------------- ------------------------------------------------------------------- -------------------------------- ----------
  **FNBMD, gr/cm** ^**2**^   0.70 ± 0.09                                                         0.93 ± 0.12                      0.001
  **FNBMD T-score**          -2.43 ± 0.64                                                        -0.85 ± 0.93                     0.001
  **FNBMD Z-score**          -1.7 ± 0.60                                                         -0.25 ± 0.86                     0.001
  **LSBMD, gr/cm** ^**2**^   0.71 ± 0.12                                                         0.97 ± 0.15                      0.001
  **LSBMD T-score**          -2.59 ± 0.86                                                        -0.75 ± 1.11                     0.001
  **LSBMD Z-score**          -1.76 ± 0.88                                                        -0.021 ± 1.14                    0.001
  **FNBMD, gr/cm** ^**2**^   0.70 ± 0.09                                                         0.93 ± 0.12                      0.001

^a^Pearson was used as appropriate with calculation of correlation coefficient.

^b^Osteoporosis at either femoral neck or lumbar spine according to international society for clinical densitometry (ISCD) criteria.

![Correlations Between BMD gr/cm^2^ and Associated Variables\
LS, lumbar spine; BMD, bone mineral density; FN, femoral neck; BMI, body mass index; WC, waist circumference \> 102 cm; FBS, fasting blood sugar.](ijem-15-01-39662-i001){#fig40682}

Characteristics of patients with and without osteoporosis are presented and compared in [Tables 1](#tbl55891){ref-type="table"} and [2](#tbl55892){ref-type="table"}). In patients with osteoporosis, prevalence of diabetes, metabolic syndrome, general obesity and abdominal obesity was significantly lower and anemia was significantly higher (P = 0.001, for all). Serum 25-hydroxyvitamin D in osteoporotic patients was non-significantly lower (P = 0.088). Prevalence of fractures in osteoporotic patients was significantly higher (P = 0.004). Prevalence of subjects taking inhaled corticosteroid was higher and those with higher level of education were significantly less common amongst osteoporotic patients (P = 0.004, and 0.009 respectively) while patients with high level of physical activity and subclinical hypothyroidism (TSH \> 5) were comparable in both groups ([Table 1](#tbl55891){ref-type="table"}).

Biochemical parameters such as serum hemoglobin, iron and ferritin were significantly lower in patients with osteoporosis (P = 0.001; P = 0.009 and P = 0.036, respectively). Serum creatinine, Ca, phosphate, uric acid, transferring, parathyroid hormone and testosterone, did not differ between the two groups. Serum 25-hydroxyvitamin D in osteoporotic patients was non-significantly higher (P = 0.051) and prevalence of 25-hydroxyvitamin D deficiency was non-significantly lower in osteoporosis (P = 0.088).

There was a positive relationship between increasing age and prevalence of osteoporosis. Prevalence of osteoporosis increased from 13% in the age group of 60 - 69 years to 36.4% in patients aged 80 years and older (P = 0.001) (data are not shown). Both FNBMD and LSBMD correlated negatively with age (r = - 0.332, P = 0.001 and -0.133, P = 0.001) ([Table 3](#tbl55893){ref-type="table"}). In regression analysis compared with age group of 60 - 69 years, age of \> 80 years was associated with significantly higher risk of osteoporosis by OR = 2.15 (95% CI, 1.009 - 4.59, P = 0.045) ([Table 4](#tbl55894){ref-type="table"}).

###### Correlation Coefficients Between Clinical and Biochemical Factors and Femoral Neck Bone Mineral Density (FNBMD) and Lumbar Spine Bone Mineral Density (LSBMD) in Elderly Males Above 60 Years Old Recruited From the Amirkola Cohort Study^[a](#fn58680){ref-type="table-fn"}^

  BMD Measurement Sites      Age             Muscle Strength, kg   BMI, kg/ m^2^   Hemoglobin, gr/dL   Ferritin, ng/mL   Abdominal Obesity^[b](#fn58681){ref-type="table-fn"}^
  -------------------------- --------------- --------------------- --------------- ------------------- ----------------- -------------------------------------------------------
  **FNBMD gr/cm** ^**2**^    -0.332, 0.001   0.363, 0.001          0.565, 0.001    0.200, 0.001        0.158, 0.001      0.462, 0.001
  **LSBMD, gr/cm** ^**2**^   -0.133, 0.001   0.237, 0.001          0.383, 0.001    0.125, 0.003        0.117, 0.006      0.309, 0.001

^a^Pearson with calculation of correlation coefficient.

^b^Waist Circumference \> 95 cm.

###### Associated Factors of Osteoporosis in Elderly Males With Calculation of Odds Ratio (OR) and Adjusted OR Using Multiple Logistic Regression Analysis^[a](#fn58682){ref-type="table-fn"},[b](#fn58683){ref-type="table-fn"},[c](#fn58683){ref-type="table-fn"}^

  Variables                                                             Unadjusted OR         P       Adjusted OR          P
  --------------------------------------------------------------------- --------------------- ------- -------------------- -------
  **Age, y**                                                                                                               
  60 - 69                                                               1                     \-      \-                   
  70 - 79                                                               0.84 (0.46 - 1.52)    0.56    0.72 (0.38 - 1.36)   0.31
  \> 80                                                                 2.15 (1.009 - 4.59)   0.046   1.60 (0.69 - 3.7)    0.27
  **BMI, kg/m** ^**2[d](#fn58684){ref-type="table-fn"}**^                                                                  
  \< 25                                                                 1                     \-      1                    
  25 - 29                                                               0.20 (0.11 - 0.36)    0.001   0.21 (0.10 - 0.42)   0.001
  \> 30                                                                 0.29 (0.07 - 0.54)    0.001   0.25 (0.06 - 0.92)   0.038
  **Serum vitamin D, ng/mL** ^**[e](#fn58685){ref-type="table-fn"}**^                                                      
  \> 30                                                                 1                     \-      1                    \-
  20 - 29                                                               0.56 (0.32 - 0.98)    0.049   0.92 (0.47 - 1.81)   0.82
  \< 20                                                                 0.61 (0.35 - 1.07)    0.095   1.3 (0.68 - 2.5)     0.41
  **Testostrone, ng/dL** ^**[f](#fn58686){ref-type="table-fn"}**^                                                          
  \< 3                                                                  1                     \-      1                    0.16
  3 - 10                                                                0.75 (0.46 - 1.21)    0.26    0.66 (0.38 - 1.17)   0.49
  \> 10                                                                 0.76 (0.31 - 1.86)    0.67    0.69 (0.25 - 1.94)   
  **Education levels**                                                                                                     
  Illiterate                                                            1                     1       1                    
  Primary school                                                        0.70 (0.41 - 1.18)    0.11    0.86 (0.47 - 1.58)   0.63
  High school and university                                            0.30 (0.11 - 0.77)    0.004   0.46 (0.15 - 1.39)   0.17
  **Physical activity** ^**[g](#fn58687){ref-type="table-fn"}**^                                                           
  \> 150 vs. \< 150                                                     1.05 (0.57 - 1.94)    0.87    0.92 (0.46 - 1.82)   0.81
  **Diabetes**                                                                                                             
  Yes vs. NO                                                            0.35 (0.18 - 0.68)    0.001   0.31 (0.13 - 0.73)   0.007
  **Metabolic syndrome**                                                                                                   
  Yes vs. No                                                            0.37 (0.23 - 0.58)    0.002   0.82 (0.45 - 1.5)    0.54
  **Inhaled corticosteroids**                                                                                              
  Yes vs. No                                                            2.66 (1.24 - 5.68)    0.017   2.16 (0.83 - 5.6)    0.11
  **Abdominal obesity** ^**[h](#fn58688){ref-type="table-fn"}**^                                                           
  Yes vs. No                                                            0.25 (0.12 - 0.51)    0.009   0.69 (0.26 - 1.85)   0.47
  **Anemia** ^**[i](#fn58689){ref-type="table-fn"}**^                                                                      
  Yes vs. No                                                            2.59 (1.50 - 4.45)    0.007   1.99 (1.03 - 3.8)    0.038
  **Smoking**                                                                                                              
  Yes vs. No                                                            0.97 (0.60 - 1.57)    0.91    0.82 (0.46 - 1.45)   0.51
  **History of fracture**                                                                                                  
  Yes vs. No                                                            1.97 (1.23 - 3.15)    0.005   2.22 (1.26 - 3.93)   0.006
  **Serum ferritin** ^**[j](#fn58690){ref-type="table-fn"}**^                                                              
  \> 100 vs. \< 100                                                     0.66 (0.42 - 1.05)    0.097   0.98 (0.57 - 1.67)   0.94
  **Quadriceps muscle**                                                                                                    
  strength \> 30 kg vs. \< 30 kg                                        0.42 (0.23 - 0.76)    0.005   0.48 (0.25 - 0.89)   0.002

^a^Osteoporosis at either femoral neck or lumbar spine according to International society for clinical densitometry (ISCD) criteria.

^b^Chi square test with calculation of 95% CI.

^d^BMD \< 25 kg/m^2^ = normal weight or underweight, 25 - 29 = overweight , \> 30 = obesity.

^e^Serum 25-OHD \< 20 ng/mL = deficiency, 20 - 29.9 = insufficiency, \> 30 = sufficiency.

^f^Serum testosterone \< 3 ng/dL = low, 3 - 10 =normal, \> 10 = high.

^g^Determined using questionnaire for daily physical activity \> 150 = high, \< 150 = low.

^h^WC \> 95 cm.

^i^Anemia defined as hemoglobin levels less than 13 gr/dL.

^j^Serum ferritin \> 100 ng/mL = high \< 100 ng/mL = low.

^c^Multiple regression analysis with calculation of 95% CI.

After adjustment for other confounders including age, metabolic syndrome, muscle strength, physical activity, educational level, history of fractures, abdominal obesity, smoking and other biochemical parameters ([Table 1](#tbl55891){ref-type="table"}), the association between age and osteoporosis decreased to a non-significant level. Subgroup analysis demonstrated a similar distribution of general and abdominal obesity as well as metabolic syndrome across various age groups but the distribution of muscle strength was inversely correlated with age (data are not shown). Prevalence of muscle strength \> 30 kg decreased by age from 61.7% in the age group of 60 - 69 years to 12.7% in the age group of \> 80 years (P = 0.001).

Body mass index was positively correlated with BMD at both measurement sites. The magnitude of Pearson correlation coefficient for BMI and FNBMD was higher than BMI and LSBMD (r = 0.565 vs. 0.383) ([Table 3](#tbl55893){ref-type="table"}).

Compared with BMI \< 25 kg/m^2^, obesity (BMI \> 30 kg/m^2^) and overweightness (BMI = 20 - 29 kg/m^2^) were associated with lower risk of osteoporosis by OR = 0.20 (95% CI, 0.11 - 0.36, P = 0.001) and OR = 0.29 (95%CI, 0.07 - 0.54, P = 0.001), respectively. After adjustment for the earlier mentioned confounders ([Table 1](#tbl55891){ref-type="table"}), lower risk of osteoporosis remained at a significant level for obese and overweight cases (OR = 0.21 (95% CI, 0.1 - 0.42, P = 0.001) and OR = 0.25 (95% CI, 0.06 - 0.0.92, P = 0.038), respectively) ([Table 4](#tbl55894){ref-type="table"}).

Diabetes was associated with significantly lower risk of osteoporosis by OR = 0.35 (95% CI, 0.18 - 0.68, P = 0.001). After adjustment for the mentioned confounders including BMI, metabolic syndrome, abdominal obesity, muscle strength and age, the risk of osteoporosis remained at a significantly lower level by adjusted OR = 0.31 (95% CI, 0.13 - 0.73, P = 0.007) ([Table 4](#tbl55894){ref-type="table"}).

Abdominal obesity was significantly correlated with both FNBMD (r = 0.462, P = 0.001) and LSBMD (r = 0.309, P = 0.001). In subjects with abdominal obesity, the risk of osteoporosis was significantly lower as compared with those without abdominal obesity by OR = 0.25 (95%CI, 0.12 - 0.51, P = 0.009) yet after correction for other clinical and biochemical confounders ([Table 1](#tbl55891){ref-type="table"}), the association reached a statistically non-significant level ([Table 4](#tbl55894){ref-type="table"}).

Metabolic syndrome was also associated with lower risk of osteoporosis compared to those without this syndrome. However, after adjustment for confounders ([Table 1](#tbl55891){ref-type="table"}), the risk of osteoporosis reached a statistically non-significant level ([Table 4](#tbl55894){ref-type="table"}).

Quadriceps muscle strength had a positive relationship with BMD at both FN and LS sites ([Table 3](#tbl55893){ref-type="table"}) and muscle strength \> 30 kg was associated with lower risk of osteoporosis compared with \< 30 kg by OR = 0.42 (95% CI, 0.23 - 0.76, P = 0.005), and after adjustment the negative association of muscle strength and osteoporosis remained at a significant level by OR = 0.48 (95%CI, 0.25 - 0.89, P = 0.002) ([Table 4](#tbl55894){ref-type="table"}).

Anemia was associated with higher risk of osteoporosis as compared with patients without anemia by OR = 1.99 (95% CI, 1.03 - 3.8, P = 0.038). In patients with history of osteoporotic fractures, the risk of osteoporosis was higher with OR = 2.22 (95% CI, 1.26 - 3.93, P = 0.0006).

High level of education was associated with non-significantly lower and inhaled corticosteroids with non-significantly higher risk of osteoporosis ([Table 4](#tbl55894){ref-type="table"}). However, high level of physical activity, vitamin D deficiency, serum level of testosterone, high serum ferritin, smoking, and subclinical hypothyroidism had no association with osteoporosis ([Table 4](#tbl55894){ref-type="table"}).

5. Discussion {#sec222598}
=============

The findings of this study indicated that 16.2% of elderly males in the geographic region of northern Iran had osteoporosis at either the hip or spine region. Among several clinical, demographic and laboratory parameters, which have been investigated, factors such as diabetes, BMI, muscle strength, metabolic syndrome, abdominal obesity and educational level were positively associated with higher BMD and lower risk of osteoporosis in univariate analyses whereas anemia, inhaled corticosteroids, history of fracture and age, were associated with lower BMD and higher risk of osteoporosis in the elderly males. However, in multivariate analyses after adjustment for all covariates, only diabetes, obesity, overweight and quadriceps muscle strength were associated with lower risk of osteoporosis, while anemia and fracture history were associated with significantly higher risk of osteoporosis. Furthermore, traditional factors such as age, smoking, vitamin D deficiency, physical inactivity, which were associated with low BMD in other studies, significantly associated with osteoporosis in this study. Although the findings of this study are supported by several previously published studies, they differ with the results of other studies ([@A39662R7]-[@A39662R9], [@A39662R16], [@A39662R19], [@A39662R26]-[@A39662R29]). Several parameters including study design, age of patients, gender, ethnicity, nutrition, body habitus, lifestyle, BMD measurement sites, prevalence and distribution of the associated factors in the general population and coexistence of these conditions in patients may explain the different results between various studies.

Prevalence of osteoporosis in another Iranian population with mean age of 54.2 ± 11.5 years was 19.9% ([@A39662R30]) and in a study on Danish males aged 60 - 74 years was 10.2% ([@A39662R27]). Difference in the prevalence of osteoporosis between populations is dependent on age, patient's characteristics, and design of the study as well as the level of participation in the epidemiological studies. Oldest and sickest individuals declined to participate, which introduced an unavoidable bias. Distance and motivation may also influence response rate and the representativeness of the cohort.

Hannan et al. ([@A39662R9]), in a meta-analysis of 167 studies found age \> 70 years, low BMI, physical inactivity, prolonged corticosteroids therapy and previous fractures as risk factors of low BMD-related fracture in males and females ([@A39662R26]). Similar findings were reported in a longitudinal study of elderly males and females ([@A39662R9]).

Age is an important cause of low BMD ([@A39662R4], [@A39662R9], [@A39662R31]). In the present study, age was inversely correlated with low BMD and osteoporosis, but the association of age with osteoporosis decreased to a non-significant level after multivariate analyses. This issue may be explained by variations in distribution of diabetes, obesity in particular muscle strength across various age groups. While diabetes and obesity were positively distributed amongst age groups, yet prevalence of patients with high muscle strength was significantly higher in younger age groups, which explained age-related differences in osteoporosis in this study (data are not shown). Therefore, disappearance of negative association with age after multivariate analyses in this study should be attributed to removing of the positive effect of muscle strength on BMD. A significant positive correlation between muscle strength and BMD, as observed in this study, was supported by Ahedi et al. ([@A39662R32]), who found a positive association between FNBMD and hip muscle cross-sectional area and muscle strength. It was shown that patients with greater and denser psoas muscles have greater LSBMD, and those with higher quadriceps muscles strength have greater FNBMD ([@A39662R28]).

In the present study, BMD in diabetes was higher than non-diabetic individuals. Similar or different results have been reported in other studies ([@A39662R33]-[@A39662R36]), which may be ascribed to differences in age of patients, gender, ethnicity or BMD measurement site. Treatment of diabetes with metformin stimulates osteoblast differentiation and hyperinsulinemia exerts anabolic on BMD ([@A39662R37]).

In this cohort study, BMI was positively correlated with BMD and the risk of osteoporosis was lower in subjects with higher BMI as compared with lower BMI, which is consistent with other studies ([@A39662R12]). Rexhepi et al. ([@A39662R12]), found an independent association between BMI and FNBMD as well as LSBMD in males and postmenopausal females. In a cross-sectional study of individuals with BMI \< 30 kg/m^2^, there was a positive linear relationship between BMI and BMD up to 30 kg/m^2^, and greater than 30 kg/m^2^ was associated with little BMD increment ([@A39662R37]). The association between BMI and BMD is race dependent. Castro et al. ([@A39662R38]), in a cross-sectional study of White and African American females found that each unit increase of BMI significantly increased BMD in White females but decreased BMD in African American females.

The positive association between obesity and BMD and lower risk of osteoporosis as observed in the present study has been supported by other previous studies ([@A39662R13], [@A39662R37]). Beneficial effect of obesity on BMD has been attributed to loading effect of weight on bone ([@A39662R13]). However, in obese or overweight individuals, both fat mass and lean body mass are components of weight. Visceral fat mass in obesity exerts a negative effect whereas lean mass confers a positive effect ([@A39662R38]). In the present study, the positive effect of metabolic syndrome and abdominal obesity on BMD disappeared after adjustment. However, data regarding metabolic syndrome and BMD are conflicting ([@A39662R39], [@A39662R40]). Among all components of metabolic syndrome, waist circumference had the strongest correlation with lower BMD ([@A39662R41]). Waist circumference, which is a diagnostic criteria for abdominal obesity and one major component of the metabolic syndrome, correlates with visceral fat mass ([@A39662R40]).

In this study, anemia and history of fractures were associated with lower BMD and higher risk of osteoporosis. The relationship between anemia and osteoporosis has been attributed to proliferation of hematopoietic cells including osteoclasts, and subsequent augmentation of bone desorption ([@A39662R41]). Meta-analysis of 11 cohorts demonstrated that prior history of fracture is associated with higher risk of subsequent fracture ([@A39662R42]).

The results of this study should be considered with limitations .We did not find a significant association between osteoporosis and inhaled corticosteroid therapy, physical inactivity, smoking, serum vitamin D deficiency and low serum testosterone. However, the results in this context are controversial across different studies. The association between smoking and osteoporosis is dose-dependent and observed mainly in heavy smokers ([@A39662R43]). Similarly, data regarding the dosage and duration of inhaled corticosteroids therapy were not provided. Nonetheless, our previous study did not show a significant bone loss in inhaled corticosteroid users amongst asthmatic patients aged \> 50 years old ([@A39662R44]). The lack of association between osteoporosis and vitamin D deficiency, low physical activity and low level of education in this cohort may be attributed to coexistence of one or more associated factors such as diabetes, obesity and anemia, in patients or inadequate sample size in some subgroups. These factors may differently affect BMD and confound the results. In this study, mean serum vitamin D was 30 ng/mL. However, sufficient levels of serum vitamin D were observed in 38.9% of patients with osteoporosis and 27.4% of those without osteoporosis, which seems to be unusual in this age group. However, data in this context are self-reported and prior injection of vitamin D cannot be ignored. Nevertheless, these findings are comparable with the general population of this geographic region ([@A39662R45]).

The strength of the study is dependent on characteristics of the cohort, which is comprised of subjects with homogenous characteristics regarding lifestyle, socio demographic characteristics, ethnicity and nutrition. All male inhabitants of a small town aged 60 years and older, who participated in BMD measurement, were recruited and thus the cohort is expected to be representative of the general population. In addition the sample size was large enough to give the results adequate power.

5.1. Conclusion {#sec222597}
---------------

The findings of this study indicate that in the geographic region of northern Iran, obesity, BMI, muscle strength and diabetes correlate positively with BMD and are associated with lower risk of osteoporosis in elderly males whereas, anemia and history of previous fractures are negatively correlated with BMD and higher risk of osteoporosis. Nonetheless, the associations of other demographic and clinical parameters like abdominal obesity, metabolic syndrome, level of education, physical activity, inhaled corticosteroids therapy, and smoking with BMD did not reach a statistical level. The design of this study was cross-sectional and the findings did not indicate causality. This issue needs a prospective longitudinal study.
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